Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities

The combination cancer immunotherapies with oncolytic virus (OV) and immune checkpoint blockade (ICB) reinstate otherwise dysfunctional antitumor CD8 T cell responses. One major mechanism that aids such reinstatement of antitumor CD8 T cells involves the availability of new class I major histocompat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Youra, Konda, Prathyusha, Murphy, J. Patrick, Paulo, Joao A., Gygi, Steven P., Gujar, Shashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864471/
https://www.ncbi.nlm.nih.gov/pubmed/34922008
http://dx.doi.org/10.1016/j.mcpro.2021.100182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864471/
https://www.ncbi.nlm.nih.gov/pubmed/34922008
http://dx.doi.org/10.1016/j.mcpro.2021.100182

Ejemplares similares